Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy
Year: 2010
Type: article
Source: Cancer Immunology Immunotherapy
Institutions: University of Pennsylvania, Advaxis (United States)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2002360129
